Developers and laboratories that make diagnostic tests would be wise to engage with legislation reintroduced in the US Congress on 24 June that would create a new regulatory framework for the products.
That’s the message from Scott Danzis, a partner in the Washington, DC, office of the law firm Covington & Burling, who says it’s important to keep an eye on the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?